Skip to main content
Figure 9 | Arthritis Research & Therapy

Figure 9

From: Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases

Figure 9

Relative risks for overall malignancies in RA patients versus general population. *Excluding nonmelanoma skin. All solid tumors. Excluding lymphatic and hematopoietic. CI, confidence interval; DMARD, disease-modifying antirheumatic drug; MTX, methotrexate; n, number of malignancies; N, population size; SIR, standardized incidence ratio; TNF, tumor necrosis factor. For original references see Smitten and coworkers [122].

Back to article page